RMP — quantitative and qualitative syphilis testing

The MMR (microprecipitation reaction) is a non-treponemal serological test used to detect antibodies that may be produced in the body in response to infection caused by the syphilis pathogen - Treponema pallidum. The study is performed on a blood sample. It is used during the initial examination for appropriate indications, as well as to assess changes in laboratory parameters after treatment.

Syphilis is an infectious disease that is transmitted mainly sexually and can affect the skin, mucous membranes, nervous system and internal organs. In the early stages, symptoms may be subtle or go unnoticed, so laboratory diagnostics are important.

What does RMP analysis determine?

RMP does not directly detect the bacterium Treponema pallidum. The test detects so-called non-treponemal antibodies, which are associated with the body's response to infection and damage to cellular structures.

The test result helps the doctor assess the likelihood of a syphilitic infection. However, the reaction can be negative at a very early stage of the disease, and a positive result sometimes occurs in other conditions. Therefore, the RMP is interpreted together with the symptoms, history, and results of additional tests.

What research options are available?

Two variants of RMP are used in laboratory diagnostics:

RMP is high quality — shows whether the reaction is positive or negative according to established laboratory criteria.
RMP quantitative — allows you to determine the reaction titer, which can be used to assess changes in the indicator over time.

The quantitative version is particularly useful when monitoring patients after treatment. Changes in titer are assessed in comparison with previous results, preferably obtained by comparable methods.

When is it recommended to take the test?

A doctor may prescribe RMP in the following cases:

during examination for suspected syphilis;
after possible contact with infection;
in the presence of ulcers or rashes that require the exclusion of syphilis;
as part of an examination before certain medical interventions or in accordance with established requirements;
to monitor treatment results;
on the recommendation of a dermatologist or other doctor.

If possible exposure to syphilis has occurred recently, a negative result does not always rule out infection. Your doctor may recommend retesting based on the time since exposure and your clinical situation.

How to prepare for the study?

Before handing over blood, follow the laboratory's recommendations for preparation. The need for fasting depends on the rules for performing a specific study and the accompanying tests that are taken at the same time.

Tell your doctor about any previous syphilis treatment and test results, if any. This information is important for the correct interpretation of your progress.

How are RMP results interpreted?

Negative result means that the reaction was not detected under the conditions of the test. However, it does not always rule out syphilis, particularly in the early stages or under certain clinical circumstances.

Positive result may indicate a syphilitic infection, but requires evaluation by a physician and, usually, additional treponemal testing. Sometimes a false-positive reaction occurs with other infections, autoimmune conditions, pregnancy, or some other circumstances.

Titer change in quantitative testing helps to assess the dynamics after treatment. Its value is determined taking into account the initial titer, control periods, symptoms and other laboratory data.

Is one RMP analysis enough to make a diagnosis?

No. The RMP is an important serological tool, but by itself does not confirm or rule out syphilis in all cases. Treponemal tests, such as TPHA/TPPA or other tests, may be used to clarify the diagnosis, according to clinical guidelines.

The final assessment of the results, the need for additional tests, and further actions are determined by the doctor.

Where to take the RMP test?

You can check availability at the Medi Lab Plus laboratory. qualitative and quantitative research options, current cost and preparation rules. If the analysis is intended for post-treatment control, it is advisable to provide the doctor with preliminary results for correct comparison of indicators.